LINC02710

Across TCGA pan-cancer cohorts, LINC02710 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02710’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02710 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02710 is over-expressed in tumor.

LUAD and BRCA are the cancer types where LINC02710 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02710 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.144	.004	2	view →
BRCA	Female	All	+0.037	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02710–LUAD

Open the LUAD breakdown →